<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did TXMD's revenue trends shift in Q4 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 08:11pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Therapeuticsmd (TXMD) experienced a revenue increase in Q4 2024, with total revenues amounting to $667,000 for the period ending December 31, 2024. This represents a positive shift in revenue trends for the company during that quarter.


|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|TXMD|TXMD.O|Therapeuticsmd|2024 Q1|-24.759615384615387|313000|185|
|TXMD|TXMD.O|Therapeuticsmd|2024 Q2|-46.453089244851256|234000|185|
|TXMD|TXMD.O|Therapeuticsmd|2024 Q3|1132.0754716981132|547000|185|
|TXMD|TXMD.O|Therapeuticsmd|2024 Q4|32.86852589641434|667000|185|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:T,comeFrom:"AInvestShareLink",events:[],answerSource:p}],fetch:{},error:q,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:h,agent_id:a,output_media_info:[],task_id:a,language:a,source:p,cache_builder:a,reply_action:"Answer",execute_mode:H,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did TXMD's revenue trends shift in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did TXMD's revenue trends shift in Q4 2024?\",\"user_id\":\"dp01947531\",\"user_name\":\"\",\"trace_id\":\"d3eb8689-7ee1-4ee9-ad6d-0fe33616b5f7\",\"session_id\":\"d3eb8689-7ee1-4ee9-ad6d-0fe33616b5f7\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:j,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue[20241231]|Report End Date|\n|---|---|---|---|---|---|\n|TXMD|Therapeuticsmd|$1.38|-1.94%|$667000|20241231|\n",query_data:{number:h,title:I,query_type:j,condition:a,model_sql:U,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e}}}],answer_chain_name:V,agent_mode:W,native_answer:a,come_from:a,text_answer:T,trace_id:i,cost:15729,event_names:a,question:g,fallback_type:X,input_type:Y,fall_back_reason:{fall_back_type:X,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2759,cache_type:"no_cache",question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:J,remote_svc:p,slots:[],answer_type:H,user_id:C,skill_name:K},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:C,question:g,source:p,raw_question:g,version:"3.4.1",action_name:K,nlu:{entity:[{type:Z,value:r,market:k}]},output_time:J,deep_research:c,deep_thinking:c,agent_mode:W},extra:{}},{answer_path:s,section:{id:t,info_texts:["Thinking"],show_type:u,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:s,section:{id:t,info_texts:["Querying Stock: TXMD Revenue in Q4 2024"],show_type:u,choice:[],result_page:{},tag_info_list:[],is_last:b,status:_},logs:[],extra:{action:$,action_input:I,thought:aa}},{answer_path:s,section:{id:t,info_texts:["Querying Stock: TXMD Revenue Change in Q4 2024"],show_type:u,choice:[],result_page:{},tag_info_list:[],is_last:b,status:_},logs:[],extra:{action:$,action_input:"TXMD Revenue Change in Q4 2024",thought:aa}},{answer_path:d,section:{id:v,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:v,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:s,section:{id:t,info_texts:["Generating Answer"],show_type:u,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:w,voice_txt:"Th",text_answer:ab,rich_text:ab,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:w,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:I,query_type:j,trace_data:a,index:h,model_sql:U,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:w,voice_txt:". This",text_answer:ac,rich_text:ac,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:x,market_id:k,name:n,domain:Z},pos:e,section_id:m,txt:n,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:v,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:v,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:v,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:w,voice_txt:"\n",text_answer:ad,rich_text:ad,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:ae,choice:[],result_page:{components:[{uuid:"cd7b54c67db57638",config:{score:145.5,show_type:af,scoreRuleNames:"dimension_magnitude;value_unit;data_size;value_unit;",showDataZoom:b,show_type_id:201,title:"柱折图",render:{ry:[{type:"line",key:D}],x:y,ly:[{type:"bar",key:E}]},title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ag,h2:a},show_type:L}},data:{chunks_info:"[]",code_count:h,columns:[{index_name:M,key:M,label:"hq_code",source:N,type:f},{domain:F,feKey:O,index_name:O,key:O,label:M,origin_index:"stock code",source:N,type:f,unit:a},{domain:F,feKey:P,index_name:P,key:P,label:"name",origin_index:"stock name",source:N,type:f,unit:a},{feKey:y,index_name:y,key:y,label:"date",origin_index:y,type:"DATE"},{domain:F,feKey:D,index_name:D,key:D,label:a,source:"calc",timestamp:a,type:ah,unit:"%"},{domain:F,feKey:E,index_name:E,key:E,label:a,source:a,timestamp:a,type:ah,unit:"USD"},{index_name:ai,key:ai,type:f}],condition:"[{\"sonSize\":5,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL TXMD.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"TXMD.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":3,\"opName\":\"or\",\"relatedSize\":0},{\"sonSize\":1,\"opName\":\"year-on-year growth rate\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Revenue\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Revenue\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:4,datas:[{code:x,"Total Revenue":313000,Ticker:r,market_code:k,"Total Revenue YoY":-24.759615384615387,Date:"2024 Q1",Name:n},{code:x,"Total Revenue":234000,Ticker:r,market_code:k,"Total Revenue YoY":-46.453089244851256,Date:"2024 Q2",Name:n},{code:x,"Total Revenue":547000,Ticker:r,market_code:k,"Total Revenue YoY":1132.0754716981132,Date:"2024 Q3",Name:n},{code:x,"Total Revenue":667000,Ticker:r,market_code:k,"Total Revenue YoY":32.86852589641434,Date:"2024 Q4",Name:n}],meta:{extra:{}},row_count:h,status_code:e,status_msg:"ok"},category:"generic",chart_type:"barLine",show_type:af,title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ag,h2:a},show_type:L},support_refresh:b,data_config:{query:a,query_type:j,data_ext_params:{}}}],global:{query_type:j},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"barline3\",\"uuid\":\"cd7b54c67db57638\"}]"},render_for:Q},data_config:{query:a,query_type:j,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"2aa92388-f1b5-4354-97d0-4aeee41d430d"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:w,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:s,section:{id:t,info_texts:["Completed"],show_type:u,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ae,choice:[{display_text:z,query_text:z,trace_info:{item_id:"b6a39dfb943a53a0a177489c39ba51cf",item_type:o,item_name:z,rec_info:aj}},{display_text:A,query_text:A,trace_info:{item_id:"f9f367f25b04cfae594dc5f8ad2c48f9",item_type:o,item_name:A,rec_info:ak}},{display_text:B,query_text:B,trace_info:{item_id:"4bc0cf8675957c31d258e7dab2b9474d",item_type:o,item_name:B,rec_info:al}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:L,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:am,related_name:an}],puuid:R,tag:a,category:"custom",uuid:ao}],global:{urp_static_data:[{name:an,value:{status_code:e,columns:[{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq},{type:f,index_name:ar,key:ar},{type:f,index_name:as,key:as},{type:f,index_name:at,key:at}],datas:[{send_text:z,item_type:o,rec_info:aj,display_text:z,rec_reason:a},{send_text:A,item_type:o,rec_info:ak,display_text:A,rec_reason:a},{send_text:B,item_type:o,rec_info:al,display_text:B,rec_reason:a}],dataSize:am,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:au,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:G,"min-height":"100%",position:av,height:G},isMaterial:c,id:au,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:S,componentUuid:ao,script:[{name:aw,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:S,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:S},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:G,position:av,height:G},isMaterial:b,_id:19,id:aw,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:Q,voice_txt:a,tracking_info:{},uuid:R},order:{is_auto:c,render_for:Q,chart_type:"command",puuid:R}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:K,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:H,answer_chain_name:V},is_deep_research:c,deep_thinking:c,create_time:1746706318984},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:q,docsData:[],quoteData:q},tplType:"question"},events:ax,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:ax,client_ip:a,question:g,user_id:C,user_name:a,trace_id:i,session_id:i,source:p,input_type:Y}}],userId:C,userName:a,startTime:J,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:q,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:q,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-txmds-revenue-trends-shift-in-q4-2024-ef5bec\u002F",config:{_app:{basePath:ay,assetsPath:ay,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"STR","How did TXMD's revenue trends shift in Q4 2024?",1,"d3eb8689-7ee1-4ee9-ad6d-0fe33616b5f7","intusstock","185","signal",2001,"Therapeuticsmd","llm_generated","ths_ainvest_lite_web",null,"TXMD.O","progress\u002Fsearching_for",1000,"searching_for",999,"rich_text","TXMD","Date","How did TXMD's revenue growth compare to industry benchmarks in Q4 2024?","What were TXMD's revenue figures for Q4 2024 compared to previous quarters?","Were there any notable changes in TXMD's market position or competitive landscape in Q4 2024?","dp01947531","Total Revenue YoY","Total Revenue","abs_国际美股领域","auto","agent","TXMD Revenue in Q4 2024",1746706303256,"review stocks","title1","code","fixed_index","Ticker","Name","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Therapeuticsmd (TXMD) experienced a revenue increase in Q4 2024, with total revenues amounting to $667,000 for the period ending December 31, 2024. This represents a positive shift in revenue trends for the company during that quarter.\n\n\n|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|\n|---|---|---|---|---|---|---|\n|TXMD|TXMD.O|Therapeuticsmd|2024 Q1|-24.759615384615387|313000|185|\n|TXMD|TXMD.O|Therapeuticsmd|2024 Q2|-46.453089244851256|234000|185|\n|TXMD|TXMD.O|Therapeuticsmd|2024 Q3|1132.0754716981132|547000|185|\n|TXMD|TXMD.O|Therapeuticsmd|2024 Q4|32.86852589641434|667000|185|\n\n","select   stock_code,   total_revenue from   ustock_fin_data where   report_end_date = date('2024y4q')   and stock_code = 'TXMD.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","thinking","Querying Stock","The user wants to analyze TXMD's revenue trend shifts in Q4 2024. I should focus on TXMD's Q4 2024 revenue and revenue change data. I will use FinQuery for the data mentioned above.","Therapeuticsmd (TXMD) experienced a revenue increase in Q4 2024, with total revenues amounting to $667,000 for the period ending December 31, 2024[^1]",". This represents a positive shift in revenue trends for the company during that quarter.\n\n","\n``` visual\n{\"uuid\":\"2aa92388-f1b5-4354-97d0-4aeee41d430d\"}\n```","result_page","barline3","TXMD Total Revenue YoY, Total Revenue","DOUBLE","market_code","2+679_496_21_554+0+0+d3eb8689-7ee1-4ee9-ad6d-0fe33616b5f7+b6a39dfb943a53a0a177489c39ba51cf+llm_generated+aimeTagAnalysis+0+0.01956893689930439+1","2+679_496_21_554+0+0+d3eb8689-7ee1-4ee9-ad6d-0fe33616b5f7+f9f367f25b04cfae594dc5f8ad2c48f9+llm_generated+aimeTagAnalysis+0+0.017627378925681114+2","2+679_496_21_554+0+0+d3eb8689-7ee1-4ee9-ad6d-0fe33616b5f7+4bc0cf8675957c31d258e7dab2b9474d+llm_generated+aimeTagAnalysis+0+0.005478313192725182+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>